S100A10, a novel biomarker in pancreatic ductal adenocarcinoma

Pancreatic cancer is arguably the deadliest cancer type. The efficacy of current therapies is often hindered by the inability to predict patient outcome. As such, the development of tools for early detection and risk prediction is key for improving outcome and quality of life. Here, we introduce the...

Descripción completa

Detalles Bibliográficos
Autores principales: Bydoun, Moamen, Sterea, Andra, Liptay, Henry, Uzans, Andrea, Huang, Weei‐Yuarn, Rodrigues, Gloria J., Weaver, Ian C.G., Gu, Hong, Waisman, David M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6210040/
https://www.ncbi.nlm.nih.gov/pubmed/30009399
http://dx.doi.org/10.1002/1878-0261.12356

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6210040/
https://www.ncbi.nlm.nih.gov/pubmed/30009399
http://dx.doi.org/10.1002/1878-0261.12356

Ejemplares similares